Lendlease, Warburg Pincus appoint Bart Price as CEO of Apac R&D joint venture

AUSTRALIAN real estate group Lendlease and US private equity giant Warburg Pincus announced on Thursday (Jan 2) that they have appointed Bart Price as chief executive officer of their life sciences, research and development (R&D) and innovation real estate joint venture (JV) platform in the Asia-Pacific (Apac), with immediate effect.

Price, who is based in Singapore, will oversee the platform’s strategic growth plans, identify opportunities to further scale it, and generate outsized returns for its investment partners.

He has two decades of career experience in real estate, infrastructure investments and capital markets across multiple markets in Apac.

Prior to this appointment, he was head of growth markets real assets at the Abu Dhabi Investment Council (ADIC), where he oversaw Apac real estate, and Apac and Latin American infrastructure. Before his time at ADIC, he held the position of senior vice-president for real estate investments covering Apac at GIC for six years.

Price said: “The Apac life sciences and R&D industry is gaining significant momentum, underpinned by multiple tailwinds such as demographic shifts, increasing healthcare demand, growing wealth, supply chain realignment, and strong government support driving robust demand for facilities.”

He added: “The platform has deep relationships and a differentiated capability in the sector, with the platform (through its prior history within Lendlease) having worked on more than 200 projects for over 100 life sciences and pharmaceutical companies over the past 20 years… I believe there are tremendous opportunities to grow the platform and deliver outsized returns to investors.”

The JV platform between Lendlease and Warburg Pincus was established in July 2024 with more than S$2 billion of assets under management. Alongside its managed investment vehicle Lino, it acquired a portfolio of assets worth around S$1.6 billion in Singapore in August 2024.